Croft-Leominster’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Croft-Leominster's MRK Position: Q4 2017 in Review
Croft-Leominster sold out of Merck (MRK) in Q4 2017, closing a stake of 3,932 shares — an estimated $240K sold.
Croft-Leominster first reported a position in MRK in Q2 2013 and held it in 17 quarters. The position peaked at $453K in Q3 2014. 2,008 funds tracked by Wall St. Rank hold MRK as of Q4 2017.
- Croft-Leominster reported no remaining Merck position as of Q4 2017 after selling out during the quarter.
- Croft-Leominster sold 3,932 Merck shares in Q4 2017, an estimated $240K.
- Croft-Leominster first reported a position in Merck in Q2 2013 and held it in 17 quarters.
- Croft-Leominster's Merck position peaked at $453K in Q3 2014.
- 2,008 funds tracked by Wall St. Rank held Merck as of Q4 2017.
Based on Croft-Leominster's 13F filing for Q4 2017, filed 6 Mar 2018.